Indicated for patients with Alagille Syndrome one year of age and older... Oct 04
FDA breakthrough therapy for Novartis metastatic prostate cancer drug ... Jun 21
FDA has ordered to simplify the Company's AR-501 Phase 2 trial design for the treatment of chronic lung infections ... Sep 09
-Advertisements-